立体定向体部放疗在乳腺癌肝转移寡转移患者中的作用。
The role of SBRT in oligometastatic patients with liver metastases from breast cancer.
作者信息
Scorsetti Marta, Franceschini Davide, De Rose Fiorenza, Comito Tiziana, Franzese Ciro, Masci Giovanna, Torrisi Rosalba, Viganò Luca, Torzilli Guido
机构信息
Departments of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
Department of Medical Oncology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
出版信息
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):163-169. doi: 10.1016/j.rpor.2016.07.008. Epub 2016 Sep 5.
Abstract
Liver metastases from breast cancer are a common occurrence. Local ablative therapies are a promising therapeutic option for these patients, with the potential for a long term disease control in the setting of "oligometastatic patients". Identification of the perfect candidate for local approaches is still challenging and unclear. Stereotactic body radiation therapy (SBRT) is one of the most valuable local therapy, because of great efficiency, low morbidity and minimal invasiveness. In this paper, we reviewed the state of the art in the care of breast cancer patients with liver metastases, with a focus on SBRT.
摘要
乳腺癌肝转移是常见现象。局部消融治疗对这些患者来说是一种有前景的治疗选择，在“寡转移患者”中具有实现长期疾病控制的潜力。确定局部治疗的理想候选者仍然具有挑战性且尚不明确。立体定向体部放射治疗（SBRT）是最有价值的局部治疗方法之一，因其效率高、发病率低且微创。在本文中，我们回顾了乳腺癌肝转移患者的治疗现状，重点是SBRT。
相似文献
1
The role of SBRT in oligometastatic patients with liver metastases from breast cancer.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):163-169. doi: 10.1016/j.rpor.2016.07.008. Epub 2016 Sep 5.
2
Stereotactic body radiation therapy for liver metastases.
J Gastrointest Oncol. 2014 Jun;5(3):190-7. doi: 10.3978/j.issn.2078-6891.2014.039.
3
A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Semin Radiat Oncol. 2018 Oct;28(4):288-294. doi: 10.1016/j.semradonc.2018.06.009.
4
[Local ablative radiotherapy of oligometastatic colorectal cancer].
Radiologe. 2017 Feb;57(2):105-110. doi: 10.1007/s00117-016-0201-z.
5
SBRT for lung oligometastases: Who is the perfect candidate?
Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):446-53. doi: 10.1016/j.rpor.2014.11.005. Epub 2014 Nov 30.
6
Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Neoplasma. 2019 Mar 5;66(2):315-325. doi: 10.4149/neo_2018_180731N558. Epub 2018 Nov 23.
7
Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.
Visc Med. 2017 Mar;33(1):54-61. doi: 10.1159/000454685. Epub 2017 Feb 3.
8
Stereotactic body radiation therapy for colorectal cancer liver metastases.
J Gastrointest Oncol. 2024 Aug 31;15(4):1917-1925. doi: 10.21037/jgo-22-1183. Epub 2023 Jun 29.
9
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview.
Front Oncol. 2019 May 1;9:337. doi: 10.3389/fonc.2019.00337. eCollection 2019.
10
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Clin Colorectal Cancer. 2017 Mar;16(1):58-64. doi: 10.1016/j.clcc.2016.07.004. Epub 2016 Jul 18.
引用本文的文献
1
ACROPath Oligometastases: The American College of Radiation Oncology Clinical Pathway.
Cureus. 2024 Nov 20;16(11):e74098. doi: 10.7759/cureus.74098. eCollection 2024 Nov.
2
Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy.
Cancers (Basel). 2023 May 19;15(10):2839. doi: 10.3390/cancers15102839.
3
Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review.
Transl Cancer Res. 2020 Aug;9(8):5087-5095. doi: 10.21037/tcr-20-1833.
4
Treatment Strategies for Oligometastatic Breast Cancer.
Curr Treat Options Oncol. 2021 Aug 23;22(10):94. doi: 10.1007/s11864-021-00889-2.
5
Radiomics of Liver Metastases: A Systematic Review.
Cancers (Basel). 2020 Oct 7;12(10):2881. doi: 10.3390/cancers12102881.
6
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer.
Front Oncol. 2020 Jun 26;10:987. doi: 10.3389/fonc.2020.00987. eCollection 2020.
7
Long-term survival results after treatment for oligometastatic brain disease.
Rep Pract Oncol Radiother. 2020 May-Jun;25(3):307-311. doi: 10.1016/j.rpor.2020.03.001. Epub 2020 Mar 4.
8
Radiotherapy for oligometastatic cancer: a survey among radiation oncologists of Lombardy (AIRO-Lombardy), Italy.
Radiol Med. 2019 Apr;124(4):315-322. doi: 10.1007/s11547-018-0972-6. Epub 2018 Dec 15.
9
Editorial.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):83-85. doi: 10.1016/j.rpor.2016.09.011. Epub 2016 Oct 15.
本文引用的文献
1
Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Breast. 2016 Apr;26:11-7. doi: 10.1016/j.breast.2015.12.002. Epub 2016 Jan 3.
2
Liver metastases and SBRT: A new paradigm?
Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):464-71. doi: 10.1016/j.rpor.2014.10.002. Epub 2014 Nov 6.
3
The role of surgery and ablative radiotherapy in oligometastatic breast cancer.
Semin Oncol. 2014 Dec;41(6):790-7. doi: 10.1053/j.seminoncol.2014.09.016. Epub 2014 Oct 7.
4
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
BMC Cancer. 2014 Aug 27;14:619. doi: 10.1186/1471-2407-14-619.
5
Stereotactic body radiation therapy for liver metastases.
J Gastrointest Oncol. 2014 Jun;5(3):190-7. doi: 10.3978/j.issn.2078-6891.2014.039.
6
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival.
Ann Oncol. 2014 Feb;25(2):467-71. doi: 10.1093/annonc/mdt537. Epub 2013 Dec 18.
7
American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).
Am J Clin Oncol. 2013 Jun;36(3):310-5. doi: 10.1097/COC.0b013e31826e053d.
8
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial.
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):336-42. doi: 10.1016/j.ijrobp.2012.12.021. Epub 2013 Feb 20.
9
Stereotactic body radiotherapy for oligometastases.
Lancet Oncol. 2013 Jan;14(1):e28-37. doi: 10.1016/S1470-2045(12)70510-7.
10
Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.
Breast Care (Basel). 2011 Oct;6(5):363-368. doi: 10.1159/000333115. Epub 2011 Oct 13.
Zotero 插件